Form 4: HomeTrust Bancshares Director Robert E. James Reports Acquisition of Restricted Stock
SEC Form 4
Director Robert E. James reports acquisition of 1,624 shares of HomeTrust Bancshares restricted stock and adjustments to holdings of common stock and stock options.
Summary
- Robert E. James, a director of HomeTrust Bancshares, reported changes in his beneficial ownership of the company's securities on May 31, 2024.
- He acquired 1,624 shares of common stock through a restricted stock award.
- These shares vest 100% on May 31, 2025.
- He also reported owning 18,071 shares of common stock directly and 1,250 shares indirectly through a 401(k).
- Additionally, he holds stock options for 12,000 shares with various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a sign of confidence, but without further context, it's difficult to gauge the overall impact.
Positives
- The acquisition of restricted stock by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- Shareholders may view the acquisition of restricted stock by a director as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 02/11/2018 | 20% of stock options granted on 02/11/2017 with exercise price of $24.95 vested. |
| 02/11/2019 | 100% of stock options granted on 02/11/2018 with exercise price of $26 vested; 20% of stock options granted on 02/11/2017 with exercise price of $24.95 vested. |
| 02/11/2020 | 100% of stock options granted on 02/11/2019 with exercise price of $27.51 vested; 20% of stock options granted on 02/11/2017 with exercise price of $24.95 vested. |
| 02/11/2021 | 20% of stock options granted on 02/11/2017 with exercise price of $24.95 vested. |
| 02/11/2022 | 20% of stock options granted on 02/11/2017 with exercise price of $24.95 vested. |
| 02/11/2027 | Expiration date for stock options with exercise price of $24.95. |
| 02/11/2028 | Expiration date for stock options with exercise price of $26. |
| 02/11/2029 | Expiration date for stock options with exercise price of $27.51. |
| 05/31/2024 | Date of transaction: acquisition of restricted stock. |
| 05/31/2025 | Vesting date for the restricted stock award. |
| 06/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.